中药内服治疗盆腔炎随机对照试验的系统评价  

The Systematical Evaluation to The Randomixed Controlled Trials of Traditional Chinese Medicine Oral Intervention Intervention in the Pelvic Inflammatory Disease(PID)

作　　者：徐俐平[1] 

机构地区：[1]广州中医药大学附属南海妇产儿童医院,广东佛山528200

出　　处：《辽宁中医杂志》2011年第2期212-214,共3页Liaoning Journal of Traditional Chinese Medicine

摘　　要：目的:系统评价中药内服干预治疗盆腔炎的随机对照试验的疗效。方法:通过检索中国生物医学文献数据库(CBM)、万方、CNKI和VIP等中文数据库(1999-2009年),全面搜集有关中药内服治疗盆腔炎的随机对照试验。由2名评价员对文献进行筛选,纳入中药治疗盆腔炎的随机对照试验并提取资料和质量评价,质量评价参照Cochranehand-book 5.0提供的标准,数据分析采用Revman 5.0软件。结果:纳入12篇随机对照研究文献,经临床异质性检验,采用固定效应模型进行Meta分析,得出中药内服治疗盆腔炎有明显的疗效且优于对照组。结论:由于中药内服治疗盆腔炎的随机对照研究开展较少,纳入研究质量较低,故中药治疗盆腔炎的有效性尚缺乏足够的证据,有待进一步研究来验证。Objective：To systematically evaluate the efficacy of traditional Chinese medicine Oral intervention in the pelvic inflammatory disease（PID）of the randomized controlled trials.Methods：to research the clinical trials by searching Chinese Biomedical Literature Database（CBM）,Wanfang,CNKI and VIP such as a database of Chinese（1999-2009）,full collection of oral administration of Chinese medicine to PID,that are randomized controlled trials.Two evaluators screening the traditional Chinese medicine treatment of PID in randomized controlled trials and extracting data and quality assessment followed Cochranehandbook5.0 criteria and data analysis software used Revman5.0.Results：The included 12 randomized controlled study,by clinical heterogeneity test,using a fixed effects model,Meta analysis resulted in traditional Chinese medicine Oral treatment of PID and the efficacy is better than the control group.Conclusion：for the fewer oral treatment of randomized controlled studies to PID,the low quality,and therefore the effectiveness of TCM treatment of PID is still a lack of sufficient evidence,pending further studies to validate.

关 键 词：中药 盆腔炎 系统评价 

分 类 号：R711.33[医药卫生—妇产科学]